224 related articles for article (PubMed ID: 16030039)
1. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
Kawasaki Y; Hosoya M; Kobayashi S; Ohara S; Onishi N; Takahashi A; Isome M; Suzuki H
Nephrol Dial Transplant; 2005 Oct; 20(10):2243-7. PubMed ID: 16030039
[TBL] [Abstract][Full Text] [Related]
2. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M; Ishihara M; Morita T; Hayashi A; Okada S; Ohta T; Sakano T; Wakiguchi H
Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of single dose of oral mizoribine pulse therapy two times per week for frequently relapsing nephrotic syndrome.
Kawasaki Y; Takano K; Isome M; Suzuki J; Suyama K; Kanno H; Fujiki T; Suzuki H; Hosoya M
J Nephrol; 2007; 20(1):52-6. PubMed ID: 17347973
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M; Ishihara M; Morita T; Hayashi A; Utsunomiya Y; Ohta T; Sakano T; Wakiguchi H
Clin Nephrol; 2008 Mar; 69(3):179-84. PubMed ID: 18397716
[TBL] [Abstract][Full Text] [Related]
5. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome.
Yoshioka K; Ohashi Y; Sakai T; Ito H; Yoshikawa N; Nakamura H; Tanizawa T; Wada H; Maki S
Kidney Int; 2000 Jul; 58(1):317-24. PubMed ID: 10886577
[TBL] [Abstract][Full Text] [Related]
6. Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome.
Kawasaki Y; Suzuki J; Takahashi A; Isome M; Nozawa R; Suzuki H
Pediatr Nephrol; 2005 Jan; 20(1):96-8. PubMed ID: 15503173
[TBL] [Abstract][Full Text] [Related]
7. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
[TBL] [Abstract][Full Text] [Related]
8. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
Ohtomo Y; Fujinaga S; Takada M; Murakami H; Akashi S; Shimizu T; Kaneko K; Yamashiro Y
Pediatr Nephrol; 2005 Dec; 20(12):1744-9. PubMed ID: 16133041
[TBL] [Abstract][Full Text] [Related]
9. Mizoribine in steroid-dependent nephrotic syndrome of childhood.
Hamasaki T; Mori M; Kinoshita Y; Saeki T; Sakano T
Pediatr Nephrol; 1997 Oct; 11(5):625-7. PubMed ID: 9323293
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD; MacLeod R; Rigby E; Clark AG
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and nephrotoxicity of a 2-year medium dose of cyclosporine in pediatric patients with steroid-dependent nephrotic syndrome: determination of the need for follow-up kidney biopsy.
Kuroyanagi Y; Gotoh Y; Kasahara K; Nagano C; Fujita N; Yamakawa S; Yamamoto M; Takeda A; Uemura O
Clin Exp Nephrol; 2018 Apr; 22(2):413-419. PubMed ID: 28699031
[TBL] [Abstract][Full Text] [Related]
12. [Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
Goto M; Ikeda M; Hataya H; Ishikura K; Hamasaki Y; Honda M
Nihon Jinzo Gakkai Shi; 2006; 48(4):365-70. PubMed ID: 16780106
[TBL] [Abstract][Full Text] [Related]
13. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Sasatomi Y; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of steroid pulse, plasmapheresis, and mizoribine in a patient with focal segmental glomerulosclerosis.
Imaizumi T; Kawasaki Y; Matsuura H; Matsumoto A; Takano K; Suyama K; Hashimoto K; Suzuki H; Hosoya M
Pediatr Nephrol; 2007 Aug; 22(8):1215-8. PubMed ID: 17347835
[TBL] [Abstract][Full Text] [Related]
15. Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome.
Kondoh T; Ikezumi Y; Yokoi K; Nakajima Y; Matsumoto Y; Kaneko M; Hasegawa H; Yamada T; Kumagai N; Ito T; Yoshikawa T
Clin Exp Nephrol; 2019 Sep; 23(9):1154-1160. PubMed ID: 31187341
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T
Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
[TBL] [Abstract][Full Text] [Related]
17. Steroid-sparing effect of mizoribine in long-term nephrotic syndrome of children.
Igarashi Y; Moro Y; Kondo Y; Inoue CN
Pediatr Nephrol; 1994 Jun; 8(3):396-7. PubMed ID: 7917877
[No Abstract] [Full Text] [Related]
18. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
Iyengar A; Karthik S; Kumar A; Biswas S; Phadke K
Indian Pediatr; 2006 Jan; 43(1):14-9. PubMed ID: 16465001
[TBL] [Abstract][Full Text] [Related]
19. Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.
Mizutani A; Fujinaga S; Sakuraya K; Hirano D; Shimizu T
Clin Exp Nephrol; 2019 Feb; 23(2):244-250. PubMed ID: 30121800
[TBL] [Abstract][Full Text] [Related]
20. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
Aizawa-Yashiro T; Tsuruga K; Watanabe S; Oki E; Ito E; Tanaka H
Pediatr Nephrol; 2011 Aug; 26(8):1255-61. PubMed ID: 21479767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
